why choose us

First received: May 29, 2024

Clinical Trial: Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteer

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-Label, Single-dose, Single Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Budesonide and Albuterol Delivered by PT027 in Healthy Chinese Participants

Brief Summary: A phase I study to assess the PK, safety, and tolerability of budesonide and albuterol delivered from a single dose of BDA MDI administered by inhalation in healthy Chinese participants.

Read more